Objective To study the relationship between neonatal morbidity (NNM) and two-year neurodevelopmental impairment (NDI) in surviving children after early fetal growth restriction (FGR).
Introduction
Perinatal researchers often use neonatal morbidities (NNMs) as surrogate outcomes for longer-term childhood outcomes in studies of early (intrauterine) exposures or interventions. 1, 2 There is evidence that specific NNMs, such as focal brain injury detected with ultrasound, bronchopulmonary dysplasia (BPD), neonatal sepsis and retinopathy, are risk factors for later development. The causal pathways for these associations may involve structural injury or more subtle white-matter damage, through interruption of oligodendrocyte maturation, for example by sepsis. 3 However these associations are imprecise, perhaps because early alterations in brain maturation during fetal life, socio-demographic characteristics and other environmental and family factors, mediate much of the longer-term outcome. [4] [5] [6] This may be especially true of babies with preterm fetal growth restriction (FGR), as this condition alone may be the main risk factor for neurodevelopmental impairment (NDI), through associated alterations in brain maturation. [7] [8] [9] In FGR pregnancies, prolonging pregnancy may lead to fetal death or fetal brain injury, owing to fetal hypoxia or prolonged malnutrition. Delivering too early may lead to neonatal death owing to prematurity or to brain injury caused by related NNMs. Thus, the relative role of NNM may be less important in determining survival without NDI following FGR.
TRUFFLE (the Trial of Randomised Fetal Flow Velocities in Europe) investigated whether ductus venosus (DV) measurement changes [as either early or late (absent A-wave) changes] combined with cardiotocography (CTG) used as a trigger for delivery, could increase the chance of a healthy outcome compared with reduced short-term variation (STV) in fetal heart rate in pregnancies complicated by FGR between 26 and 32 weeks' gestation. 10 The primary outcome was defined as survival without NDI at 2 years of age corrected for preterm birth. A composite of NNMs was a secondary outcome and did not differ between study groups. In contrast, the use of DV measures was associated with an increased proportions of babies surviving free of NDI.
In this secondary analysis we aimed to explore the relationship between NNM and survival with and without NDI at 2 years of age. In addition, because NNM is strongly associated with gestational age 1 and severity of FGR, 11, 12 we aimed to explore whether NNM and NDI are associated similarly across gestational age and birthweight ratio (BWR) subgroups. Finally we aimed to explore which prenatal and delivery factors, apart from neonatal risk factors, are associated with NDI.
Methods
The design and principal outcomes for TRUFFLE have been described previously. 10, 12 In short, women with a singleton pregnancy at 26-32 weeks' gestation, with fetal abdominal circumference <10th percentile, estimated fetal weight ≥500 g and umbilical artery Doppler pulsatility index (PI) >95th percentile, were included in a twenty-centre European study (ISRCTN 56204499). Baseline maternal and fetal data were collected via a secure internet data entry page. Study group allocation was performed in an even ratio from randomly sized blocks, stratified by gestational age (lower or higher than 29 weeks' gestation) and participating centre. Eligible women were randomly allocated for delivery according to one of three monitoring arms: reduced CTG fetal heart rate STV of <3.5 ms at a gestational age below 29 weeks and <4.0 ms thereafter; early DV changes (PI > 95th percentile); or late DV changes (a-wave at or below baseline, hereafter referred to as 'DV-noA 0 '). Abnormal DV measurements had to be repeated within 24 hours, if permitted by other measures of fetal condition, to demonstrate that this was a consistent observation. In all groups delivery could also be decided on 'safety-net criteria' when the CTG showed recurrent decelerations, or in the DV groups when STV was very low (STV <2.6 ms at a gestational age below 29 weeks and <3.0 ms thereafter).
Gestational age was calculated using a first-trimester dating ultrasound scan or, in the absence of an early scan, from the date of the last menstrual period if supported by later ultrasound findings.
The BWR, defined as the ratio of birthweight to the median (50th percentile) weight for gestational age adjusted for maternal ethnicity, weight and length and infant sex, was calculated as a measure of the severity of FGR following Gardosi et al. 13 A BWR of 0.86 is comparable to the 10th percentile and a BWR of 0.68 to the 2.3 rd percentile on a birthweight curve.
Severe NNM was registered as a composite of one or more of the following severe morbidities: severe germinal matrix cerebral haemorrhage [GMH; intraventricular haemorrhage with dilation of the lateral ventricles (grade III) or intraparenchymal haemorrhage (grade IV)], cystic periventricular leucomalacia (PVL), proven neonatal sepsis (positive blood culture requiring treatment with antibiotics), necrotising enterocolitis (Bell's stage 2 or greater: presence of pneumatosis or perforation on X-ray or identified by laparotomy) and BPD, defined as needing supplemental oxygen at 36 weeks postmenstrual age. Neonatal data were extracted from clinical records and entered directly into the website study database.
Surviving children and their parents were invited to the follow-up clinic in each of the participating institutions. Development was assessed using the Bayley-III Scales of Infant and Toddler Development.
14 Cognitive outcome is reported as the composite cognitive scale, with a normed mean of 100 and an SD of 15. For some children only the second edition of the Bayley Scales was available. To compensate for discrepancies between editions of the Bayley Scales, 15 five points were added to Bayley II Mental developmental index (MDI) scores. If no Bayley test could be performed because of impairment, the attending paediatrician was asked to assess an estimate of cognitive delay (no delay, 3-6 months or more than 6 months' delay).
All assessed children had a formal neurological examination to see if cerebral palsy (CP) -which was classified using the Surveillance of Cerebral Palsy in Europe classification -was present. The functional severity of CP was scored using the Gross Motor Function Classification System (GMFCS). NDI was defined as a Cognitive Bayley III score or corrected Bayley II MDI of <85 or an estimated cognitive delay of >3 months, CP with a GMFCS >1, hearing loss requiring a hearing aid or severe visual loss (legally certifiable as blind or partially sighted).
Differences between groups were compared using ANOVA, Pearson's chi-square or Fisher's exact test as appropriate. To assess the impact of NNM, odds ratios (OR) with 95% CIs were calculated for NDI and constituent disabilities. The group of 402 infants was subsequently divided into five gestational-age groups (26-27, 28-29, 30-31, 32-33 and ≥34 weeks) and six BWR groups (<0.40, 0.4-0.5, 0.5-0.6, 0.6-0.7, 0.7-0.8 and ≥0.8); the relationship between gestational-age group and BWR group and the proportions with NNM and NDI were analysed.
Multivariable logistic regression analysis was used to assess the association between a range of factors and outcomes. We used a dichotomous dependent variable (NDI versus no NDI) and included independent factors that were significantly associated with two-year outcomes in univariate analysis. The study group was forced into the final model. IBM SPSS version 22 (New York, NY, USA) was used for statistical analysis.
Results
Among the 503 births to women entered into TRUFFLE, 41 babies died before 2 years of age, neonatal information on one baby was unavailable and we excluded 59 children who were not examined at two years, leaving 402/461 (87%) survivors for this analysis (see our earlier publication for flowchart 10 ). The children included were representative of the whole cohort (Table 1 ) over a range of factors. Ninety-two percent of the Truffle cohort received antenatal corticosteroids. We have no data on placental microscopy. However, 99% of all liveborn infants were delivered by caesarean section before the onset of labour, which makes chorioamnionitis unlikely. There were no differences in demographic, obstetric or neonatal variables between the randomised fetal monitoring groups and between infants with or without follow-up at 2 years (data shown in our earlier paper 10 ). Consistent with the main trial findings, 10 among the 402 included children who survived and were examined at 2 years of age, there was a trend in the proportion without NDI across the three trial groups, being highest in the DVnoA 0 group and lowest in the STV group (P = 0.02). NNM was more common among those with NDI [24% versus 44%; OR, 2.5 (95% CI, 1.3-4.8); P = 0.01], but in Table 1 . Randomisation allocation and primary study outcome 
CTG-STV, cardiotocography fetal heart rate short-term variation; DV-noA 0 , ductus venosus a-wave at or below baseline; DV-P95, ductus venosus pulsatility index >95th percentile; NEC, necrotising enterocolitis; RDS, respiratory distress syndrome. Data are given as n, n (%) or n/N (% The proportion with NNM fell rapidly from 68% at 26-27 weeks' gestation to 11% at 34 weeks (P < 0.001). There was a non-significant reduction in NDI from 16% at 26-27 weeks to 8% at ≥34 weeks (P = 0.40; Figure 1A ). Similarly, the proportion with NDI fell from 17% at a BWR of <0.4 to 9% at a BWR of ≥0.8 (P = 0.06) but there was no relationship between BWR and NNM (P = 0.98; Figure 1B) .
We used stepwise multivariable analysis to explore the relationship between NDI and those factors significantly associated with outcome on univariable analysis (Table 2) , including trial allocation with CTG-STV allocation as the reference group. In the final model, six factors were independently associated with NDI at 2 years. Cerebral ultrasound abnormality was the strongest negative associate [OR, 19.0 (95% CI 4.2-85.2)] but it was only present in 3% of the population, contributing 15% of the variance in Table 2 . Demographic, obstetric and neonatal data in 402 women in the study, specified for long-term primary outcome at the corrected age of two years
Parameter
Outcome at age 24 months corrected age (n = 402) BPD, bronchopulmonary dysplasia (defined as need for supplemental oxygen at 36 weeks' gestation); GMH, germinal matrix haemorrhage; NDI, neurodevelopmental impairment; NEC, necrotizing enterocolitis; OR, odds ratio; PVL, cystic periventricular leucomalacia. Data are given as n (%), mean AE SD or median (interquartile range). *U/C ratio, umbilical artery pulsatility index (PI) / median cerebral artery PI ratio. **Birthweight p50 ratio, ratio of birthweight to median (50th percentile) weight for gestational age, adjusted for maternal ethnicity, weight, length and infant sex.
2-year outcomes. In male infants and infants with Apgar scores of <7 and a lower BWR, NDI was also seen more frequently. Allocation to each DV monitoring group as part of the trial was associated with a lower frequency of NDI. Receiver-operating characteristic curve analysis had an area under the curve of 0.78 for the final model, consistent with a poor prediction.
Discussion

Main findings
In surviving preterm infants born after severe FGR the risk for NDI was increased by the presence of severe NNM [OR, 2.5 (95% CI, 1.3-4.8)] but for 56% (95% CI, 41-72%) infants with NDI, NDI was not preceded by any of the components of our NNM composite. While the presence of NNM was strongly associated with gestational age at birth, the proportion with NDI did not differ significantly over the gestational-age range. In contrast, the relationship of BWR was clearer for NDI than for NNM. Multivariable analysis identified key protective factors, including the study allocation to the two DV monitoring arms, and one major neonatal risk factor. We have thus shown that in preterm babies born after FGR composite NNM appears to be a poor proxy outcome for NDI-free survival.
Strengths and limitations of the study
The strengths of this study were the large prospective sample of children born after FGR in several European countries. Also, the use of BWR, rather than a cut-off of < the 5th percentile or < the 10th percentile for birthweight, provided further insight into the degree of FGR and its relationship with both NNM and NDI. Limitations were the loss to follow-up of 13%, which had nothing to do with GA, BWR or NNM. NDI occurred at a rather low rate of 10%, therefore further exploration of associations between pregnancy, delivery and NNM (the last aim of this paper) lacked power.
Interpretation
Current perinatal practice is to delay the delivery of very preterm fetuses with growth restriction to a later (4) 3 (1) 0.08 3.9 (0.9-17.9) NDI, neurodevelopmental impairment; OR, odds ratio. Data are given as n (%). *No Bayley score available. Figure 1 . Bar plots showing rates of neonatal morbidity (NNM) ( ) and neurodevelopmental impairment (NDI) ( ) with respect to gestational age (GA) (A) and birthweight ratio (BWR) (B). There was a significant relationship between NNM and GA (P < 0.001), but not between NDI and GA (P = 0.40). There was no significant relationship between NNM and BWR (P = 0.98), and a borderline significant relationship between NDI and BWR (P = 0.06).
gestational age. 7 However delaying delivery does require close monitoring of the fetus, as increasing the degree of growth restriction (reducing the BWR) is also associated with adverse outcome. Preterm birth is associated with reduced overall and regional brain volumes. Using magnetic resonance imaging (MRI), babies born after preterm FGR have been shown to have lower brain volumes shortly after birth and at term-term equivalent age than do normally grown preterm infants. 16 This deficit comprised mainly reduced grey-matter volume, with a lesser effect on the white matter. A further study in very-lowbirth-weight infants found an association between fetal Doppler indices and 2-year development, and suggested that this association was mediated through lower brain volume, which was measured at term-equivalent age using MRI. 5 However, the effect of the severity of FGR (as expressed by BWR) on brain volume in prospectively followed fetuses was not evaluated, but a progressive effect on brain growth seems plausible. Thus timing of delivery balances the risk for NNM by earlier delivery and NDI with increasing FGR by later delivery. Additionally we have confirmed in this multivariable analysis that using either of the two DV monitoring strategies in TRUFFLE is associated with reduced long-term morbidity compared with reliance on STV on CTG.
This study intended to investigate whether there was a strong relationship between NNM and NDI; we did not find such a relationship. Moreover, of all the components of NNM, in our multivariate analysis only cerebral ultrasound abnormalities were kept in the model and were significantly associated with NDI. Cerebral ultrasound abnormalities are most frequent in the most preterm fetuses and are probably a consequence of neonatal immaturity. However, this study was not designed to demonstrate an increased risk of major GMH or PVL associated with FGR. Strategies that prevent brain injury would be preventing fetal and perinatal acidosis or swings in cerebral blood pressure before delivery. 17, 18 It is worth noting that most cerebral ultrasound abnormalities occurred in the DV groups (4.2% in the combined DV groups versus 0.6% in the STV group; P < 0.05), 9 but this may simply reflect improved survival at low gestational ages.
We here demonstrate a larger vulnerability for males [0.87 (95% CI, 0.77-0.98)] for NDI. In the literature on outcomes after FGR sex differences are hardly reported. 8 One study found that in 4-year-old children born with FGR after early-onset hypertensive complications of pregnancy, abnormal neurodevelopmental outcome was also associated with male sex. 19 In this study a rather low rate of NDI was found. Because of inconsistencies in defining FGR in the literature and differentiation from small-for-gestational-age, comparing our NDI rate with those of other studies is challenging. 8 Previously we suggested that a conservative approach to timing delivery in waiting for late DV changes -unless severe CTG changes defined as a 'safety net' occur first -was associated with a more favourable 2-year outcome. 10 However, the age of two is rather early in child development and further follow-up, probably at least until school age, [19] [20] [21] would provide extra insight into the consequences of FGR and interventions that influence timing of delivery, because cognitive development, together with other measures of neuropsychiatric functioning, can better be assessed at that age, with less emphasis on motor and social development.
Conclusion
Although, in FGR infants, the presence of NNM is highly associated with impairment at 2 years of age, it appears to be a poor proxy for NDI as a primary outcome, as the majority of those with NDI have no NNM. Considering individual NNMs, the predictive value is best for cerebral ultrasound abnormalities, which are relatively infrequent compared with NDI. Until better short-term markers of long-term NDI are identified, perinatal studies with important neurological outcomes should plan 2-year outcome evaluations at the very least.
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